|
1
|
Yang YT, Wang YF, Lai JY, Shen SY, Wang F,
Kong J, Zhang W and Yang HY: Long non-coding RNA UCA1 contributes
to the progression of oral squamous cell carcinoma by regulating
the WNT/β-catenin signaling pathway. Cancer Sci. 107:1581–1589.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Z, Wu C, Xie N and Wang P: Long
non-coding RNA MEG3 inhibits the proliferation and metastasis of
oral squamous cell carcinoma by regulating the WNT/β-catenin
signaling pathway. Oncol Lett. 14:4053–4058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leusink FK, van Es RJ, de Bree R,
Baatenburg de Jong RJ, van Hooff SR, Holstege FC, Slootweg PJ,
Brakenhoff RH and Takes RP: Novel diagnostic modalities for
assessment of the clinically node-negative neck in oral
squamous-cell carcinoma. Lancet Oncol. 13:e554–e561. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng G, Xun W, Wei K, Yang Y and Shen H:
MicroRNA-27a-3p regulates epithelial to mesenchymal transition via
targeting YAP1 in oral squamous cell carcinoma cells. Oncol Rep.
36:1475–1482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takenaka K, Chen BJ, Modesitt SC, Byrne
FL, Hoehn KL and Janitz M: The emerging role of long non-coding
RNAs in endometrial cancer. Cancer Genet. 209:445–455. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith A, Teknos TN and Pan Q: Epithelial
to mesenchymal transition in head and neck squamous cell carcinoma.
Oral Oncol. 49:287–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
da Silva SD, Morand GB, Alobaid FA, Hier
MP, Mlynarek AM, Alaoui-Jamali MA and Kowalski LP:
Epithelial-mesenchymal transition (EMT) markers have prognostic
impact in multiple primary oral squamous cell carcinoma. Clin Exp
Metastasis. 32:55–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao C, Wu CH and Hu HZ: LncRNA UCA1
promotes epithelial-mesenchymal transition (EMT) of breast cancer
cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 20:2819–2824. 2016.PubMed/NCBI
|
|
10
|
Liu H, Zhen Q and Fan Y: LncRNA GHET1
promotes esophageal squamous cell carcinoma cells proliferation and
invasion via induction of EMT. Int J Boil Markers. 32:e403–e408.
2017. View Article : Google Scholar
|
|
11
|
Liang J, Liang L, Ouyang K, Li Z and Yi X:
MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis
through Wnt/β-catenin signaling pathway. J Oral Pathol Med.
46:98–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Graham LD, Pedersen SK, Brown GS, Ho T,
Kassir Z, Moynihan AT, Vizgoft EK, Dunne R, Pimlott L, Young GP, et
al: Colorectal Neoplasia Differentially Expressed (CRNDE), a novel
gene with elevated expression in colorectal adenomas and
adenocarcinomas. Genes Cancer. 2:829–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu T, Zhang X, Yang YM, Du LT and Wang
CX: Increased expression of the long noncoding RNA CRNDE-h
indicates a poor prognosis in colorectal cancer, and is positively
correlated with IRX5 mRNA expression. Onco Targets Ther.
9:1437–1448. 2016.PubMed/NCBI
|
|
14
|
Szafron LM, Balcerak A, Grzybowska EA,
Pienkowska-Grela B, Podgorska A, Zub R, Olbryt M, Pamula-Pilat J,
Lisowska KM, Grzybowska E, et al: The putative oncogene, CRNDE, is
a negative prognostic factor in ovarian cancer patients.
Oncotarget. 6:43897–43910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jing SY, Lu YY, Yang JK, Deng WY, Zhou Q
and Jiao BH: Expression of long non-coding RNA CRNDE in glioma and
its correlation with tumor progression and patient survival. Eur
Rev Med Pharmacol Sci. 20:3992–3996. 2016.PubMed/NCBI
|
|
16
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Z, Yu C, Zhan L, Pan Y, Chen L and
Sun C: LncRNA CRNDE promotes hepatic carcinoma cell proliferation,
migration and invasion by suppressing miR-384. Am J Cancer Res.
6:2299–2309. 2016.PubMed/NCBI
|
|
18
|
Riis P: The helsinki declaration of the
world medical association (WMA). Ethical principles of medical
research involving human subjects. Pol Merkur Lekarski. 36:298–301.
2014.(In Polish).
|
|
19
|
Jiang H, Wang Y, Ai M, Wang H, Duan Z,
Wang H, Zhao L, Yu J, Ding Y and Wang S: Long noncoding RNA CRNDE
stabilized by hnRNPUL2 accelerates cell proliferation and migration
in colorectal carcinoma via activating Ras/MAPK signaling pathways.
Cell Death Dis. 8:e28622017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Subhash S, Andersson PO, Kosalai ST,
Kanduri C and Kanduri M: Global DNA methylation profiling reveals
new insights into epigenetically deregulated protein coding and
long noncoding RNAs in CLL. Clin Epigenetics. 8:1062016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ellis BC, Graham LD and Molloy PL: CRNDE,
a long non-coding RNA responsive to insulin/IGF signaling,
regulates genes involved in central metabolism. Biochim Biophys
Acta 1843. 372–386. 2014.
|
|
23
|
Gao H, Song X, Kang T, Yan B, Feng L, Gao
L, Ai L, Liu X, Yu J and Li H: Long noncoding RNA CRNDE functions
as a competing endogenous RNA to promote metastasis and oxaliplatin
resistance by sponging miR-136 in colorectal cancer. OncoTargets
Ther. 10:205–216. 2017. View Article : Google Scholar
|
|
24
|
Zheng J, Liu X, Wang P, Xue Y, Ma J, Qu C
and Liu Y: CRNDE promotes malignant progression of glioma by
attenuating miR-384/PIWIL4/STAT3 axis. Mol Ther. 24:1199–1215.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang DM, Lin ZY, Yang ZH, Wang YY, Wan D,
Zhong JL, Zhuang PL, Huang ZQ, Zhou B and Chen WL: IncRNA H19
promotes tongue squamous cell carcinoma progression through
β-catenin/GSK3β/EMT signaling via association with EZH2. Am J
Transl Res. 9:3474–3486. 2017.PubMed/NCBI
|
|
26
|
Liu Y: Epithelial to mesenchymal
transition in renal fibrogenesis: Pathologic significance,
molecular mechanism, and therapeutic intervention. J Am Soc
Nephrol. 15:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee MY and Shen MR: Epithelial-mesenchymal
transition in cervical carcinoma. Am J Transl Res. 4:1–13.
2012.PubMed/NCBI
|
|
28
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tse JC and Kalluri R: Mechanisms of
metastasis: Epithelial-to-mesenchymal transition and contribution
of tumor microenvironment. J Cell Biochem. 101:816–829. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chiurillo MA: Role of the Wnt/β-catenin
pathway in gastric cancer: An in-depth literature review. World J
Exp Med. 5:84–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo J, Xia N, Yang L, Zhou S, Zhang Q,
Qiao Y and Liu Z: GSK-3β and vitamin D receptor are involved in
β-catenin and snail signaling in high glucose-induced
epithelial-mesenchymal transition of mouse podocytes. Cell Physiol
Biochem. 33:1087–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scheel C and Weinberg RA: Cancer stem
cells and epithelial- mesenchymal transition: Concepts and
molecular links. Semin Cancer Biol. 22:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Müller T, Bain G, Wang X and Papkoff J:
Regulation of epithelial cell migration and tumor formation by
beta-catenin signaling. Exp Cell Res. 280:119–133. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shan Y, Zhang L, Bao Y, Li B, He C, Gao M,
Feng X, Xu W, Zhang X and Wang S: Epithelial-mesenchymal
transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail,
ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J
Nutr Biochem. 24:1062–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang LP, Chen SW, Zhuang SM, Li H and Song
M: Galectin-3 accelerates the progression of oral tongue squamous
cell carcinoma via a Wnt/β-catenin-dependent pathway. Pathol Oncol
Res. 19:461–474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huan J, Xing L, Lin Q, Xui H and Qin X:
Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway
through acting as a molecular sponge of microRNA-136 in human
breast cancer. Am J Transl Res. 9:1977–1989. 2017.PubMed/NCBI
|
|
38
|
Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu
XY, Yu ZW, Jia YH, Bai XF, Li L, et al: The lncRNA CRNDE promotes
colorectal cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar : PubMed/NCBI
|
